Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Crucell Switzerland (Vivotif Operations)

M&A STATUS
71-80 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of travel vaccines. The unit manufactures and distributes travel vaccines for typhoid and hepatitis A.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Switzerland

Crucell Switzerland (Vivotif Operations) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Crucell Switzerland (Vivotif Operations)‘s full profile, request access.

Request full access to PitchBook

Crucell Switzerland (Vivotif Operations) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Crucell Switzerland (Vivotif Operations)‘s full profile, request access.

Request full access to PitchBook